These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21780072)
1. [Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine]. Gracia-Naya M; Santos-Lasaosa S; Ríos-Gómez C; Sánchez-Valiente S; García-Gomara MJ; Latorre-Jiménez AM; Artal-Roy J; Mauri-Llerda JA Rev Neurol; 2011 Aug; 53(4):201-8. PubMed ID: 21780072 [TBL] [Abstract][Full Text] [Related]
2. [A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol]. Gracia-Naya M; Huerta-Villanueva M; Rios C; Garcia-Gomara MJ; Artal-Roy J; Sanchez-Valiente S; Santos-Lasaosa S; Mauri-Llerda JA; Latorre-Jimenez AM Rev Neurol; 2012 Mar; 54(5):277-83. PubMed ID: 22362476 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients]. Gracia-Naya M; Huerta-Villanueva M; Ríos-Gómez C; Latorre-Jiménez AM; Sánchez-Valiente S; Santos-Lasaosa S; Mauri-Llerda JA; García-Gómara MJ; Artal-Roy J Rev Neurol; 2010 May; 50(9):513-9. PubMed ID: 20443169 [TBL] [Abstract][Full Text] [Related]
4. [A comparative study of the effectiveness of topiramate and flunarizine in independent series of chronic migraine patients without medication abuse]. Gracia-Naya M; Ríos C; García-Gomara MJ; Sánchez-Valiente S; Mauri-Llerda JÁ; Santos-Lasaosa S; Artal-Roy J; Latorre-Jiménez AM Rev Neurol; 2013 Oct; 57(8):347-53. PubMed ID: 24081889 [TBL] [Abstract][Full Text] [Related]
5. [Topiramate or flunarizine in the preventive treatment of migraine. A comparative study of two series of cases]. Gracia-Naya M; Latorre-Jiménez AM Rev Neurol; 2005 Dec 16-31; 41(12):705-8. PubMed ID: 16355353 [TBL] [Abstract][Full Text] [Related]
6. [Preventive treatment with topiramate enhances the quality of life of patients with migraine]. Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422 [TBL] [Abstract][Full Text] [Related]
7. Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients. Garcia-Monco JC; Foncea N; Bilbao A; Ruiz de Velasco I; Gomez-Beldarrain M Cephalalgia; 2007 Aug; 27(8):920-8. PubMed ID: 17645757 [TBL] [Abstract][Full Text] [Related]
8. [Does medication abuse in patients with chronic migraine influence the effectiveness of preventive treatment with topiramate?]. Gracia-Naya M; Hernando-Quintana N; Latorre-Jimenez AM; Rios C; Artal-Roy J; Garcia-Gomara MJ; Santos-Lasaosa S; Sanchez-Valiente S; Mauri-Llerda JA Rev Neurol; 2014 Nov; 59(9):385-91. PubMed ID: 25342051 [TBL] [Abstract][Full Text] [Related]
9. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Limmroth V; Biondi D; Pfeil J; Schwalen S Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489 [TBL] [Abstract][Full Text] [Related]
10. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ; Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971 [TBL] [Abstract][Full Text] [Related]
14. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J; Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844 [TBL] [Abstract][Full Text] [Related]
15. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396 [TBL] [Abstract][Full Text] [Related]
17. [Preventive treatment of chronic migraine with zonisamide: a study in patients who are refractory or intolerant to topiramate]. Pascual-Gómez J; Alañá-García M; Oterino A; Leira R; Láinez-Andrés JM Rev Neurol; 2008 Nov 1-15; 47(9):449-51. PubMed ID: 18985592 [TBL] [Abstract][Full Text] [Related]
18. Canadian Headache Society guideline for migraine prophylaxis. Pringsheim T; Davenport W; Mackie G; Worthington I; Aubé M; Christie SN; Gladstone J; Becker WJ; Can J Neurol Sci; 2012 Mar; 39(2 Suppl 2):S1-59. PubMed ID: 22683887 [TBL] [Abstract][Full Text] [Related]
19. Testing the combination beta-blocker plus topiramate in refractory migraine. Pascual J; Rivas MT; Leira R Acta Neurol Scand; 2007 Feb; 115(2):81-3. PubMed ID: 17212609 [TBL] [Abstract][Full Text] [Related]
20. An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine. Krymchantowski AV; Jevoux C; Moreira PF Pain Med; 2010 Jan; 11(1):48-52. PubMed ID: 20002594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]